ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

701 hedge funds and large institutions have $22.4B invested in Alexion Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 122 funds opening new positions, 245 increasing their positions, 247 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

1% less repeat investments, than reductions

Existing positions increased: 245 | Existing positions reduced: 247

19% less call options, than puts

Call options by funds: $305M | Put options by funds: $378M

Holders
701
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$305M
Puts
$378M
Net Calls
Net Calls Change

Top Buyers

1 +$297M
2 +$226M
3 +$125M
4
First Trust Advisors
First Trust Advisors
Illinois
+$112M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$97.7M

Top Sellers

1 -$196M
2 -$152M
3 -$124M
4
CS
Credit Suisse
Switzerland
-$119M
5
Artisan Partners
Artisan Partners
Wisconsin
-$95.7M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$43.2M
77
$42.5M
78
$42.4M
79
$42.1M
80
$38.9M
81
$38.6M
82
$37.6M
83
$37.2M
84
$37M
85
$36.7M
86
$35.6M
87
$35.5M
88
$34.6M
89
$34.6M
90
$34M
91
$33.9M
92
$33.7M
93
$33.3M
94
$33.3M
95
$32.9M
96
$32.6M
97
$30M
98
$29.7M
99
$28.7M
100
$27.3M